Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05638360

Evaluation of the Curative Effect of Ru-Yi-Jin-Huang-Saan

Evaluation of the Efficacy of Ru-Yi-Jin-Huang-Saan on Colles' Fracture ---a Randomized, Double-blind, Placebo-controlled Trial

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Changhua Christian Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of Ru-Yi-Jin-Huang-Saan for the treatment of Colles' fracture.

Detailed description

According to the definition of the World Health Organization, Taiwan officially entered the aged society in 2018. The population over the age of 65 exceeds 14% of the total population. Based on this, it is estimated that we will enter a super-aged society in 2026. Because the older the age, the higher the rate of bone loss, and the higher the risk of osteoporosis, the easier it is to fracture due to falls. The incidence of bone fracture is directly proportional to the aging population. Traditional Chinese Medicine(TCM) interventional fracture treatment has a long history and experience. Many recent studies show that TCM is benefit to reduce risk of total hip replacement and has a positive influence on the prevention of osteoporotic fracture. In drug mechanism research, some Chinese herbal medicine has been proved to promote bone fracture healing . Although most of these researches have been confirmed in the laboratory, little information is available on true patients. In clinical we observe a lot of topical Chinese medicine been used after fracture, so the purpose of this thesis is to investigate the effective of topical Chinese herbal paste. This study may lead to build the usage of guideline after fracture.

Conditions

Interventions

TypeNameDescription
DRUGRu Yi Jin Huang PowderEach patch contains 13g Ru Yi Jin Huang Powder and 10c.c. water.
DRUGPlaceboEach patch contains 13g starch and 10c.c. water.

Timeline

Start date
2023-05-01
Primary completion
2025-06-30
Completion
2025-09-30
First posted
2022-12-06
Last updated
2025-03-19

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05638360. Inclusion in this directory is not an endorsement.